184 related articles for article (PubMed ID: 27149063)
1. RAD51B in Familial Breast Cancer.
Pelttari LM; Khan S; Vuorela M; Kiiski JI; Vilske S; Nevanlinna V; Ranta S; Schleutker J; Winqvist R; Kallioniemi A; Dörk T; Bogdanova NV; Figueroa J; Pharoah PD; Schmidt MK; Dunning AM; García-Closas M; Bolla MK; Dennis J; Michailidou K; Wang Q; Hopper JL; Southey MC; Rosenberg EH; Fasching PA; Beckmann MW; Peto J; Dos-Santos-Silva I; Sawyer EJ; Tomlinson I; Burwinkel B; Surowy H; Guénel P; Truong T; Bojesen SE; Nordestgaard BG; Benitez J; González-Neira A; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Brüning T; Lindblom A; Margolin S; Mannermaa A; Hartikainen JM; Chenevix-Trench G; ; Van Dyck L; Janssen H; Chang-Claude J; Rudolph A; Radice P; Peterlongo P; Hallberg E; Olson JE; Giles GG; Milne RL; Haiman CA; Schumacher F; Simard J; Dumont M; Kristensen V; Borresen-Dale AL; Zheng W; Beeghly-Fadiel A; Grip M; Andrulis IL; Glendon G; Devilee P; Seynaeve C; Hooning MJ; Collée M; Cox A; Cross SS; Shah M; Luben RN; Hamann U; Torres D; Jakubowska A; Lubinski J; Couch FJ; Yannoukakos D; Orr N; Swerdlow A; Darabi H; Li J; Czene K; Hall P; Easton DF; Mattson J; Blomqvist C; Aittomäki K; Nevanlinna H
PLoS One; 2016; 11(5):e0153788. PubMed ID: 27149063
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
3. Screening of HELQ in breast and ovarian cancer families.
Pelttari LM; Kinnunen L; Kiiski JI; Khan S; Blomqvist C; Aittomäki K; Nevanlinna H
Fam Cancer; 2016 Jan; 15(1):19-23. PubMed ID: 26351136
[TBL] [Abstract][Full Text] [Related]
4. ATM variants and cancer risk in breast cancer patients from Southern Finland.
Tommiska J; Jansen L; Kilpivaara O; Edvardsen H; Kristensen V; Tamminen A; Aittomäki K; Blomqvist C; Børresen-Dale AL; Nevanlinna H
BMC Cancer; 2006 Aug; 6():209. PubMed ID: 16914028
[TBL] [Abstract][Full Text] [Related]
5. A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer.
Pelttari LM; Kiiski J; Nurminen R; Kallioniemi A; Schleutker J; Gylfe A; Aaltonen LA; Leminen A; Heikkilä P; Blomqvist C; Bützow R; Aittomäki K; Nevanlinna H
J Med Genet; 2012 Jul; 49(7):429-32. PubMed ID: 22652533
[TBL] [Abstract][Full Text] [Related]
6. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
7. Germline mutation in the RAD51B gene confers predisposition to breast cancer.
Golmard L; Caux-Moncoutier V; Davy G; Al Ageeli E; Poirot B; Tirapo C; Michaux D; Barbaroux C; d'Enghien CD; Nicolas A; Castéra L; Sastre-Garau X; Stern MH; Houdayer C; Stoppa-Lyonnet D
BMC Cancer; 2013 Oct; 13():484. PubMed ID: 24139550
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer.
Kohlhase S; Bogdanova NV; Schürmann P; Bermisheva M; Khusnutdinova E; Antonenkova N; Park-Simon TW; Hillemanns P; Meyer A; Christiansen H; Schindler D; Dörk T
PLoS One; 2014; 9(1):e85334. PubMed ID: 24465539
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
Pylkäs K; Tommiska J; Syrjäkoski K; Kere J; Gatei M; Waddell N; Allinen M; Karppinen SM; Rapakko K; Kääriäinen H; Aittomäki K; Blomqvist C; Mustonen A; Holli K; Khanna KK; Kallioniemi OP; Nevanlinna H; Winqvist R
Carcinogenesis; 2007 May; 28(5):1040-5. PubMed ID: 17166884
[TBL] [Abstract][Full Text] [Related]
10. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.
Freedman ML; Penney KL; Stram DO; Le Marchand L; Hirschhorn JN; Kolonel LN; Altshuler D; Henderson BE; Haiman CA
Hum Mol Genet; 2004 Oct; 13(20):2431-41. PubMed ID: 15317758
[TBL] [Abstract][Full Text] [Related]
11. Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Michailidou K; Hall P; Gonzalez-Neira A; Ghoussaini M; Dennis J; Milne RL; Schmidt MK; Chang-Claude J; Bojesen SE; Bolla MK; Wang Q; Dicks E; Lee A; Turnbull C; Rahman N; ; Fletcher O; Peto J; Gibson L; Dos Santos Silva I; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Czene K; Irwanto A; Liu J; Waisfisz Q; Meijers-Heijboer H; Adank M; ; van der Luijt RB; Hein R; Dahmen N; Beckman L; Meindl A; Schmutzler RK; Müller-Myhsok B; Lichtner P; Hopper JL; Southey MC; Makalic E; Schmidt DF; Uitterlinden AG; Hofman A; Hunter DJ; Chanock SJ; Vincent D; Bacot F; Tessier DC; Canisius S; Wessels LF; Haiman CA; Shah M; Luben R; Brown J; Luccarini C; Schoof N; Humphreys K; Li J; Nordestgaard BG; Nielsen SF; Flyger H; Couch FJ; Wang X; Vachon C; Stevens KN; Lambrechts D; Moisse M; Paridaens R; Christiaens MR; Rudolph A; Nickels S; Flesch-Janys D; Johnson N; Aitken Z; Aaltonen K; Heikkinen T; Broeks A; Veer LJ; van der Schoot CE; Guénel P; Truong T; Laurent-Puig P; Menegaux F; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Zamora MP; Perez JI; Pita G; Alonso MR; Cox A; Brock IW; Cross SS; Reed MW; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Henderson BE; Schumacher F; Le Marchand L; Andrulis IL; Knight JA; Glendon G; Mulligan AM; ; ; Lindblom A; Margolin S; Hooning MJ; Hollestelle A; van den Ouweland AM; Jager A; Bui QM; Stone J; Dite GS; Apicella C; Tsimiklis H; Giles GG; Severi G; Baglietto L; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Brenner H; Müller H; Arndt V; Stegmaier C; Swerdlow A; Ashworth A; Orr N; Jones M; Figueroa J; Lissowska J; Brinton L; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Brauch H; Hamann U; Brüning T; ; Radice P; Peterlongo P; Manoukian S; Bonanni B; Devilee P; Tollenaar RA; Seynaeve C; van Asperen CJ; Jakubowska A; Lubinski J; Jaworska K; Durda K; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Bogdanova NV; Antonenkova NN; Dörk T; Kristensen VN; Anton-Culver H; Slager S; Toland AE; Edge S; Fostira F; Kang D; Yoo KY; Noh DY; Matsuo K; Ito H; Iwata H; Sueta A; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Shu XO; Lu W; Gao YT; Cai H; Teo SH; Yip CH; Phuah SY; Cornes BK; Hartman M; Miao H; Lim WY; Sng JH; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Shen CY; Hsiung CN; Wu PE; Ding SL; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Blot WJ; Signorello LB; Cai Q; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Simard J; Garcia-Closas M; Pharoah PD; Chenevix-Trench G; Dunning AM; Benitez J; Easton DF
Nat Genet; 2013 Apr; 45(4):353-61, 361e1-2. PubMed ID: 23535729
[TBL] [Abstract][Full Text] [Related]
12. A role for XRCC2 gene polymorphisms in breast cancer risk and survival.
Lin WY; Camp NJ; Cannon-Albright LA; Allen-Brady K; Balasubramanian S; Reed MW; Hopper JL; Apicella C; Giles GG; Southey MC; Milne RL; Arias-Pérez JI; Menéndez-Rodríguez P; Benítez J; Grundmann M; Dubrowinskaja N; Park-Simon TW; Dörk T; Garcia-Closas M; Figueroa J; Sherman M; Lissowska J; Easton DF; Dunning AM; Rajaraman P; Sigurdson AJ; Doody MM; Linet MS; Pharoah PD; Schmidt MK; Cox A
J Med Genet; 2011 Jul; 48(7):477-84. PubMed ID: 21632523
[TBL] [Abstract][Full Text] [Related]
13. Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.
Fletcher O; Johnson N; dos Santos Silva I; Orr N; Ashworth A; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Waltes R; Bremer M; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Humphreys K; Liu J; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; ; ; Beesley J; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Ko YD; Hamann U; ; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Milne RL; Benítez J; Arias JI; Pita G; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Broeks A; Schmidt MK; van Leeuwen FE; Van't Veer LJ; Margolin S; Lindblom A; Humphreys MK; Morrison J; Platte R; Easton DF; Peto J;
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2143-51. PubMed ID: 20826828
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families.
Johnson J; Healey S; Khanna KK; ; Chenevix-Trench G
Breast Cancer Res Treat; 2011 Aug; 129(1):255-63. PubMed ID: 21533530
[TBL] [Abstract][Full Text] [Related]
15. Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy.
Silvestri V; Rizzolo P; Scarnò M; Chillemi G; Navazio AS; Valentini V; Zelli V; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Pensotti V; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D; Ottini L
Eur J Cancer; 2015 Nov; 51(16):2289-95. PubMed ID: 26248686
[TBL] [Abstract][Full Text] [Related]
16. Germline RAP80 mutations and susceptibility to breast cancer.
Akbari MR; Ghadirian P; Robidoux A; Foumani M; Sun Y; Royer R; Zandvakili I; Lynch H; Narod SA
Breast Cancer Res Treat; 2009 Jan; 113(2):377-81. PubMed ID: 18306035
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.
Lin WY; Camp NJ; Ghoussaini M; Beesley J; Michailidou K; Hopper JL; Apicella C; Southey MC; Stone J; Schmidt MK; Broeks A; Van't Veer LJ; Th Rutgers EJ; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Peto J; Dos-Santos-Silva I; Fletcher O; Johnson N; Bolla MK; Wang Q; Dennis J; Sawyer EJ; Cheng T; Tomlinson I; Kerin MJ; Miller N; Marmé F; Surowy HM; Burwinkel B; Guénel P; Truong T; Menegaux F; Mulot C; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Benitez J; Zamora MP; Arias Perez JI; Menéndez P; González-Neira A; Pita G; Alonso MR; Alvarez N; Herrero D; Anton-Culver H; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Meindl A; Lichtner P; Schmutzler RK; Müller-Myhsok B; Brauch H; Brüning T; Ko YD; ; Tessier DC; Vincent D; Bacot F; Nevanlinna H; Aittomäki K; Blomqvist C; Khan S; Matsuo K; Ito H; Iwata H; Horio A; Bogdanova NV; Antonenkova NN; Dörk T; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Neven P; Wauters E; Wildiers H; Lambrechts D; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Manoukian S; Bonanni B; Couch FJ; Wang X; Vachon C; Purrington K; Giles GG; Milne RL; Mclean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; Hassan N; Vithana EN; Kristensen V; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; García-Closas M; Figueroa J; Lissowska J; Brinton L; Czene K; Darabi H; Eriksson M; Brand JS; Hooning MJ; Hollestelle A; Van Den Ouweland AM; Jager A; Li J; Liu J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cross SS; Reed MW; Blot W; Signorello LB; Cai Q; Pharoah PD; Perkins B; Shah M; Blows FM; Kang D; Yoo KY; Noh DY; Hartman M; Miao H; Chia KS; Putti TC; Hamann U; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; Mckay J; Slager S; Toland AE; Yannoukakos D; Shen CY; Hsiung CN; Wu PE; Ding SL; Ashworth A; Jones M; Orr N; Swerdlow AJ; Tsimiklis H; Makalic E; Schmidt DF; Bui QM; Chanock SJ; Hunter DJ; Hein R; Dahmen N; Beckmann L; Aaltonen K; Muranen TA; Heikkinen T; Irwanto A; Rahman N; Turnbull CA; ; Waisfisz Q; Meijers-Heijboer HE; Adank MA; Van Der Luijt RB; Hall P; Chenevix-Trench G; Dunning A; Easton DF; Cox A
Hum Mol Genet; 2015 Jan; 24(1):285-98. PubMed ID: 25168388
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study.
Laaksovirta H; Peuralinna T; Schymick JC; Scholz SW; Lai SL; Myllykangas L; Sulkava R; Jansson L; Hernandez DG; Gibbs JR; Nalls MA; Heckerman D; Tienari PJ; Traynor BJ
Lancet Neurol; 2010 Oct; 9(10):978-85. PubMed ID: 20801718
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants within microRNA-binding site of RAD51B are associated with risk of cervical cancer in Chinese women.
Hang D; Zhou W; Jia M; Wang L; Zhou J; Yin Y; Ma H; Hu Z; Li N; Shen H
Cancer Med; 2016 Sep; 5(9):2596-601. PubMed ID: 27334422
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants at 14q24.1 and breast cancer susceptibility: a fine-mapping study in Chinese women.
Ma H; Li H; Jin G; Dai J; Dong J; Qin Z; Chen J; Wang S; Wang X; Hu Z; Shen H
DNA Cell Biol; 2012 Jun; 31(6):1114-20. PubMed ID: 22313133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
